Degos disease mimicking primary vasculitis of the CNS

A 4-year-old boy developed a headache. Initial evaluation revealed a normal neurologic examination and a right subdural hygroma on CT. Worsening headaches led to hospitalization at an outside institution. MRI showed leptomeningeal enhancement; magnetic resonance angiography (MRA) was normal. Infectious, rheumatologic, hematologic, and CSF studies were unrevealing. He then developed a left-sided hemiparesis. Imaging showed increased leptomeningeal enhancement with punctate infarcts in the right hemisphere. CT angiography demonstrated irregularity involving branches of the circle of Willis suggestive of vasculitis. Methylprednisolone (30 mg·kg⁻¹·d⁻¹ × 5 days) was administered for presumed CNS vasculitis.

Despite continued glucocorticoid therapy, the patient developed increasing left-sided weakness. Repeat imaging showed perivascular inflammation. Headaches continued and examination revealed left-sided hemiparesis, new-onset right leg weakness, bilateral clonus, and extensor plantar responses. IV cyclophosphamide (dosed every 2 weeks for 4 doses; titrated to 1,000 mg/m²) was initiated for presumed CNS vasculitis. Rituximab (750 mg/m² × 2 doses) and IV immunoglobulin (2 g/kg divided over 4 days) were added for worsening MRI findings. However, he developed new multifocal infarcts. Infliximab (5 mg/kg) was initiated based on use in resistant CNS vasculitis.¹ Two months after initial diagnosis, the patient was transferred to our institution for a second opinion.

Upon transfer, examination revealed weakness of the left face, arm, and leg; continued right leg weakness; a left homonymous hemianopsia; and bilateral clonus and extensor plantar responses. Spinal and brain MRI revealed multiple spinal cord lesions and acute infarcts in the anterolateral right pons. The patient developed right cranial nerve III palsy. He developed abdominal pain (attributed to neurogenic bladder and constipation). Abdominal and pelvic MRA and serologies did not demonstrate systemic vasculitis.

Based on his subdural fluid collections, abdominal pain, and the refractory nature of his vascular process, Degos disease was proposed as a unifying diagnosis.² Previously rash-free, the patient was now noted to have a 4-mm porcelain white abdominal papule with central atrophy and an erythematous rim (figure, C). A papule with a dull pink-gray center and red telangiectatic rim was present on his right foot (figure, D). Skin biopsy revealed central epidermal atrophy with hyperkeratosis and increased dermal mucin and fibrin thrombi (figure, F). Small dermal vessels demonstrated degeneration of their walls, leading to a smudged appearance (figure, F). Eculizumab³ and treprostinil⁴ were initiated for presumed Degos.

• Download figure
• Open in new tab
• Download powerpoint

Figure Neurologic, gastrointestinal, and dermatologic findings

(A) Coronal section of the brain. In the right hemisphere, there are multiple hemorrhages in white matter, hippocampus, basal gray matter, and extensive hemorrhagic cortical infarction. (B) MRI fluid-attenuated inversion recovery image shows bilateral subdural collections (arrows) with extensive subacute infarcts and hemorrhage, predominantly on the right. (C) A 4-mm porcelain white papule with central atrophy and an erythematous rim on the patient's left abdomen. (D) Papule with a dull pink gray center and red rim present on the right medial plantar foot. (E) Deposition of membrane attack complex C5b-9 in vessel walls, immunoperoxidase ×10. (F) High-power view of the skin shows increased mucin (arrow) around dermal vessels. The vessel walls have a smudged appearance and 2 are filled with fibrin thrombi. (G) White porcelain lesions (arrow) on the proximal bowel serosa seen at autopsy. Microscopically, these areas show increased mucin, abnormal vessels with degenerating, smudged vessel walls, and thrombi in medium-sized vessels.

The patient developed worsening abdominal pain. He was found to have 3 gastric perforations, which were repaired. He developed right upper extremity myoclonic movements necessitating intubation for sedation. MRI demonstrated worsened right-sided and new left hemispheric leptomeningeal enhancement, as well as a new subacute right thalamic infarct extending to the brainstem (figure, B). Anti-VLA4 therapy (natalizumab; 5 mg/kg) was added to reduce CD4 T-cell access into the CNS. MRI 1 week later revealed increasing bilateral hemispheric disease and progression of the deep gray nuclei and brainstem lesions. Palliative care was provided; the patient died of respiratory failure after elective extubation.

• Received December 1, 2015.
• Accepted in final form January 4, 2016.

• © 2016 American Academy of Neurology